ROC curves were plotted to determine the optimal cut-off value for GP73 and to identify the sensitivity and specificity of GP73 and AFP in differentiating patients with malignant and benign solid liver tumors (HCC vs. HCA and FNH). This evidence concerns the gene GOLM1 and hepatocellular carcinoma.